3m's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is 3m's ROA in the second quarter of 2026?
3m Company achieved a return on average assets (ROA) of 7.39 % in its second quarter of 2026, which is below 3m's average return on assets, which stands at 12.18%.

However, within the Healthcare sector 112 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 832, from total ROA ranking in the first quarter of 2026 at 846.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	30.99 %	-9.98 %	5.59 %	-7.93 %	-12.51 %
Y / Y Net Income Change	29.38 %	-41.27 %	-21.15 %	-38.88 %	-37.01 %
Net Income (TTM) in million	3,012	2,799	3,262	3,416	3,951
Return On Assets (TTM)	7.39 %	7.39 %	8.4 %	8.92 %	10.1 %
MMM's Total Ranking	# 832	# 846	# 700	# 619	# 557
Total Assets (TTM) in million	49,012	35,436	41,559	37,074	37,416
Seq. Total Assets Change	38.31 %	-14.73 %	12.1 %	-0.91 %	-4.95 %
Seq. Net Income Change	42.34 %	14.81 %	-31.75 %	16 %	-35.38 %

MMM's 5 Years Annual ROA >> Back to MMM Management Effectiveness >> Compare MMM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 32
Sector	# 113
Overall	# 743

Return On Assets Statistics
High	Average	Low
19.47 %	12.18 %	-15.39 %
(March 31, 2007)		(Sep 30 2023)

Financial Statements
3m's Assets	$ 49,012 million	MMM's Balance sheet
3m's Income	$ 938 million	Quarterly MMM's Income Statement
MMM's Income by Division		See MMM's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-3.99 %	-21.11 %	9.19 %	-1.27 %	-0.57 %
Total Assets in million	37,733	39,303	49,821	45,626	46,214
Y / Y Net Income Change	-22.11 %	-	-	-2.33 %	10.04 %
Net Income in million	3,262	4,188	-6,979	5,791	5,929
Annual Return On Assets	8.64 %	10.66 %	-14.01 %	12.69 %	12.83 %

MMM's 5 Years Annual ROA >> Back to MMM Management Effectiveness >> Compare MMM ROA to its Competitors

Comment on MMM's ROA in the fiscal year ending 2025

In the fiscal year 2025 3m's ROA decreased compared to previous year to 8.64 %, due to deterioration of net income -22.11 % to $3,262.00 million, from $4,188.00 million a year ago, as MMM's assets were $37,733.00 million.

More Return On Assets Ratios
MMM's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MMM's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MMM's Competitors
Subscribers only: Roa for 3m's Suppliers
Subscribers only: Return On Assets for MMM's Customers

You may also want to know
MMM's Roi	MMM's Inventory Turnover Ratio	MMM's Growth Rates	MMM's Dividend Comparisons
	MMM's Profitability Ratios	MMM's Asset Turnover Ratio	MMM's Dividend Growth
MMM's Roe	MMM's Valuation Ratios	MMM's Financial Strength Ratios	MMM's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %

Date modified: 2026-09-12T06:19:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.